Innovation
Consensus among experts.
Evaluation System
HRCT (High-Resolution Computed Tomography).
Assessment
The follow-up of patients with severe post-COVID-19 pneumonia and pulmonary complications focuses on periodic assessments to detect and manage interstitial lung disease and other respiratory sequelae. Monthly post-discharge visits are recommended, including symptom questionnaires and treatment evaluation, with imaging tests if corticosteroids were used. At 2-3 months, an evaluation includes blood tests, pulmonary function tests, and imaging studies, tailored to clinical progress. At 6 months, these assessments are repeated if symptoms or abnormalities persist, prioritising early identification of potential complications such as pulmonary fibrosis using HRCT.
References
Sibila O, Molina-Molina M, Valenzuela C, Ríos-Cortés A, Arbillaga-Etxarri A, Torralba García Y, Díaz-Pérez D, Landete P, Mediano O, Tomás López L, Rodríguez Pascual L, Jara-Palomares L, López-Reyes R, de la Rosa Carrillo D. Consensus document of the Spanish Society of Pulmonology and Thoracic Surgery (SEPAR) for post-COVID-19 clinical follow-up: Evaluation of interstitial lung disease in severe pneumonia and/or pulmonary complications. Open Respir Arch. 2020;2(4):278-283. doi:10.1016/j.opresp.2020.09.002